Filtered By:
Cancer: Acute Myeloid Leukemia
Drug: Cipro
This page shows you your search results in order of date.
Order by Relevance | Date
Total 4 results found since Jan 2013.
Antibacterial prophylaxis in pediatric patients with leukemia
ConclusionAntibacterial prophylaxis mainly with coverage against Gram-positive bacteria is recommended in pediatric patients with AML. For ALL patients, prophylaxis may be considered for patients who are undergoing intensive chemotherapy phases and are at high risk for infections with ciprofloxacin being the most commonly used agent. In general more studies are needed to determine the role of antibacterial prophylaxis in pediatric patients with leukemia.
Source: Saudi Pharmaceutical Journal - July 10, 2018 Category: Drugs & Pharmacology Source Type: research
Antibacterial prophylaxis in pediatric patients with leukemia.
Conclusion Antibacterial prophylaxis mainly with coverage against Gram-positive bacteria is recommended in pediatric patients with AML. For ALL patients, prophylaxis may be considered for patients who are undergoing intensive chemotherapy phases and are at high risk for infections with ciprofloxacin being the most commonly used agent. In general more studies are needed to determine the role of antibacterial prophylaxis in pediatric patients with leukemia.
Source: Saudi Pharmaceutical Journal - April 4, 2018 Category: Drugs & Pharmacology Source Type: research